Richard C. Rosenzweig - 01 Feb 2023 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Reporting relationship: SVP and General Counsel
Issuer ticker: ANGO
Reported as of: 01 Feb 2023
Net transaction value: -$15,190
SEC form: 4
Accepted by SEC: 07 Feb 2023, 15:00:52 UTC
Prior SEC filing: 22 Jul 2022
Next SEC filing: 02 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Richard C. Rosenzweig

Key filing fact

Richard C. Rosenzweig filed Form 4 for ANGIODYNAMICS INC (ANGO) on 07 Feb 2023.

Key facts

This page summarizes Richard C. Rosenzweig's Form 4 filing for ANGIODYNAMICS INC (ANGO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Feb 2023, 15:00.

Change

Previous filing in this sequence was filed on 22 Jul 2022.
Current net transaction value: -$15,190.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANGO transaction

Common Stock

Tax liability

Transaction value: $15,190
Shares: -1,137
Change %: -6.7%
Price: $13.36
Shares after: 15,730
Date: 01 Feb 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The exempt disposition of 1,137 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on February 1, 2021.